Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial-Reference-Cited by-同舟云学术

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial

Published:2013-10 Issue:8 Volume:1 Page:610-620
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Valery Patricia C,Morris Peter S,Byrnes Catherine A,Grimwood Keith,Torzillo Paul J,Bauert Paul A,Masters I Brent,Diaz Abbey,McCallum Gabrielle B,Mobberley Charmaine,Tjhung Irene,Hare Kim M,Ware Robert S,Chang Anne B

Funder

National Health and Medical Research Council (NHMRC) of Australia

Australian Research Council Future Fellowship

NHMRC fellowship

NHMRC Gustav Nossal Postgraduate Scholarship

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference44 articles.

1. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand;Chang;Med J Aust,2010

2. Emerging drugs for bronchiectasis;Chang;Expert Opin Emerg Drugs,2012